Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2065–2088 of 196,761 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: ALL Clear all

Conditions: Depression, Anxiety, Bipolar Disorder
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years and older
Enrollment: 193 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pediatric Aggression and Violence
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 7 Years to 9 Years · Male only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Cancer, Cognitive Impairment
Interventions: COPE +; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Opioid Use, Opioid Prescribing
Interventions: Short-acting opioid prescription for acute pain; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 1,709 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 5
States / cities: Birmingham, Alabama • Los Angeles, California • New Haven, Connecticut + 2 more

Conditions: Atrial Fibrillation (AF)
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: H Pylori Infection, H Pylori Gastritis, Gastric Cancer
Interventions: PYTEST® 14C-Urea Breath Test, VOQUEZNA® Triple Pak®; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 430 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: CLL, SLL, Richter's Transformation, Indolent Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Aggressive Lymphoma, DLBCL, Mediastinal Large B-cell Lymphoma, MCL
Interventions: TG-1801, Ublituximab; Biological
Lead sponsor: TG Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 5
States / cities: Fayetteville, Arkansas • Hackensack, New Jersey • Chattanooga, Tennessee + 2 more

Conditions: Thrombotic Microangiopathy
Interventions: Ravulizumab, Best Supportive Care; Drug · Other
Lead sponsor: Alexion Pharmaceuticals, Inc.; Industry
Eligibility: Up to 17 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 8
States / cities: Tucson, Arizona • Aurora, Colorado • Atlanta, Georgia + 5 more

Conditions: Cigarette Smoker, Current Smoker, Former Smoker, Multiple Pulmonary Nodules, Pulmonary Nodule
Interventions: Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18 L-glutamate Derivative BAY94-9392, Positron Emission Tomography (PET/CT); Diagnostic Test · Drug
Lead sponsor: Andrei Iagaru; Other
Eligibility: 45 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Prostate Adenocarcinoma, Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIIC Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
Interventions: Hormone Therapy, Stereotactic Body Radiation Therapy; Drug · Radiation
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Dysphagia
Interventions: RE-ACTIVE, PRO-ACTIVE EAT, PRO-ACTIVE EAT + EXERCISE; Behavioral
Lead sponsor: University Health Network, Toronto; Other
Eligibility: 18 Years and older
Enrollment: 952 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 10
States / cities: Miami, Florida • Orlando, Florida • Baltimore, Maryland + 7 more

Conditions: Knee Osteoarthritis
Interventions: Double leg press with partial blood flow restriction, Double leg press without partial blood flow restriction; Device · Other
Lead sponsor: University of Iowa; Other
Eligibility: 45 Years and older · Male only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Meditation, Cognitive Reappraisal, Emotional Regulation
Interventions: Inner Engineering Program; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 15 Years to 18 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alcohol-induced Disorders, Alcohol Drinking, Mental Health
Interventions: Strengths-based linkage to alcohol care, Usual care; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Little Rock, Arkansas • Palo Alto, California

Conditions: Type 1 Diabetes
Interventions: Isolated Human Pancreatic Islets; Biological
Lead sponsor: Andrew Posselt; Other
Eligibility: 18 Years to 90 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV Infections, Pregnancy
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 1 Day to 6 Months
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 8
States / cities: La Jolla, California • Long Beach, California • Los Angeles, California + 1 more

Conditions: Diabetic Wounds, Venous Stasis Wounds
Interventions: injection of lipoaspirate, control; Procedure · Other
Lead sponsor: Washington D.C. Veterans Affairs Medical Center; Federal
Eligibility: 20 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Prostate Cancer
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 40 Years to 75 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Healthy Infants
Interventions: Changing chat; Device
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 16 Months to 18 Months
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Mitral Valve Insufficiency, Heart Failure
Interventions: Surgical mitral valvuloplasty with placement of annular ring (SMVR), Optimal medical therapy (OMT); Procedure · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 8
States / cities: Atlanta, Georgia • Boston, Massachusetts • Minneapolis, Minnesota + 5 more

Conditions: Lennox-Gastaut Syndrome, Dravet Syndrome
Interventions: 12-Lead ECG, Cannabidiol; Procedure · Drug
Lead sponsor: Gillette Children's Specialty Healthcare; Other
Eligibility: 2 Years to 30 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Cerebral Microvascular Circulation
Interventions: Mechanical ventilation adjustment; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Lung Cancer
Interventions: Telehealth Palliative Care, In-person Palliative Care; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 1,798 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 23
States / cities: Birmingham, Alabama • Los Angeles, California • San Francisco, California + 18 more

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia
Interventions: sorafenib tosylate, pharmacological study, laboratory biomarker analysis; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen

Pediatric Aggression and Violence

Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention

Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations

Developing MRI Technologies for Atrial Fibrillation

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Study of Ravulizumab in Pediatric Participants With HSCT-TMA

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer

Assessment of Efficacy of Low Intensity Resistance Training in Men at Risk for Symptomatic Knee Osteoarthritis

Transforming Adolescent Perception and Mental Health Through Meditation and Cognitive Reappraisal A Mixed Method Study

Strengths-based Linkage to Alcohol Care (SLAC) for Hazardous Drinkers in Primary Care

Pancreatic Islet Transplantation Into the Gastric Submucosa

Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants

The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers

Markers for Early Detection of Prostate Cancer

Changing Chat: Diaper Tips to Improve Language Development

Effectiveness of Surgical Mitral Valve Repair Versus Medical Treatment for People With Significant Mitral Regurgitation and Non-ischemic Congestive Heart Failure

The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy

Assessment of Cerebral Microvascular Circulation

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia